JP2024520526A5 - - Google Patents

Info

Publication number
JP2024520526A5
JP2024520526A5 JP2023573331A JP2023573331A JP2024520526A5 JP 2024520526 A5 JP2024520526 A5 JP 2024520526A5 JP 2023573331 A JP2023573331 A JP 2023573331A JP 2023573331 A JP2023573331 A JP 2023573331A JP 2024520526 A5 JP2024520526 A5 JP 2024520526A5
Authority
JP
Japan
Prior art keywords
oral composition
amino acid
less
composition according
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023573331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520526A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/031330 external-priority patent/WO2022251624A1/en
Publication of JP2024520526A publication Critical patent/JP2024520526A/ja
Publication of JP2024520526A5 publication Critical patent/JP2024520526A5/ja
Pending legal-status Critical Current

Links

JP2023573331A 2021-05-28 2022-05-27 アミノ酸水分補給剤及び使用方法 Pending JP2024520526A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163194567P 2021-05-28 2021-05-28
US63/194,567 2021-05-28
PCT/US2022/031330 WO2022251624A1 (en) 2021-05-28 2022-05-27 Amino acid hydration formulation and method of use

Publications (2)

Publication Number Publication Date
JP2024520526A JP2024520526A (ja) 2024-05-24
JP2024520526A5 true JP2024520526A5 (cg-RX-API-DMAC7.html) 2025-06-04

Family

ID=84230290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023573331A Pending JP2024520526A (ja) 2021-05-28 2022-05-27 アミノ酸水分補給剤及び使用方法

Country Status (9)

Country Link
US (1) US20240252580A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346793A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024520526A (cg-RX-API-DMAC7.html)
KR (1) KR20240013777A (cg-RX-API-DMAC7.html)
CN (1) CN118369093A (cg-RX-API-DMAC7.html)
AU (1) AU2022280087A1 (cg-RX-API-DMAC7.html)
CA (1) CA3221410A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023014015A (cg-RX-API-DMAC7.html)
WO (1) WO2022251624A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11878073B1 (en) * 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein
US20240341342A1 (en) * 2023-04-11 2024-10-17 Paul Knox High efficancy hydration composion, production method, and use.
KR102794409B1 (ko) * 2023-10-31 2025-04-14 (주)링티 피로회복과 지구력 증진 효과를 가지는 신규한 아미노산 조성물 및 이의 용도
EP4686419A1 (en) * 2024-07-29 2026-02-04 Salssa Enterprises S.L. Food composition, and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561111A (en) * 1994-12-23 1996-10-01 The University Of Virginia Patent Foundation Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
GB9609993D0 (en) * 1996-05-14 1996-07-17 Norbrook Lab Ltd Oral rehydration product
CA2863388C (en) * 2012-02-08 2020-11-17 Sadasivan Vidyasagar Materials and methods for treating diarrhea
CN104159457B (zh) * 2012-03-09 2016-08-17 株式会社明治 水分吸收性优异的饮食品
EP3148563B1 (en) * 2014-05-23 2019-05-22 Kyowa Hakko Bio Co., Ltd. Methods and compositions for enhancement of ability to concentrate
HRP20200940T1 (hr) * 2014-11-19 2020-09-18 Kalmarna Limited Otopina za oralnu rehidraciju i njene metode
CN112753922A (zh) * 2021-01-25 2021-05-07 北京大学第三医院(北京大学第三临床医学院) 一种促进恢复的固体运动饮料及其制备方法
WO2023183846A1 (en) * 2022-03-23 2023-09-28 The Coca-Cola Company Enhanced hydration beverages with improved taste

Similar Documents

Publication Publication Date Title
ES2221385T3 (es) Preparaciones de gabapentina y pregabalina estabilizadas con aminoacidos y procedimiento para prepararlas.
JP2020530845A5 (cg-RX-API-DMAC7.html)
JP2020502183A5 (cg-RX-API-DMAC7.html)
JP2018012722A5 (cg-RX-API-DMAC7.html)
US10682325B2 (en) Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
JP2005518361A5 (cg-RX-API-DMAC7.html)
US7939113B2 (en) Nutritional composition for facilitating muscle pumps
US5034377A (en) Aqueous nutrient compositions comprising oligopeptides
JP2013525484A5 (cg-RX-API-DMAC7.html)
WO2007133642A8 (en) Sport drink containing amino acids and carbohydrates
JP2020504108A5 (cg-RX-API-DMAC7.html)
JPS61247354A (ja) 栄養素組成物
GB1511302A (en) Pharmaceutical compositions comprising amino acid analogues
NO155239B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, blandede salter av essensielle eller semi-essensielle aminosyrer og nitrogenfri analoger derav.
WO2016203499A4 (en) Synergistic beverage composition
JP2020073699A5 (cg-RX-API-DMAC7.html)
JP2025106502A (ja) アスコルビン酸及び/又はその塩を含有する外用組成物
RU2009126763A (ru) Лечение общих расстройств развития
JP2007517038A5 (cg-RX-API-DMAC7.html)
CN103948588A (zh) 复方氨基酸注射液及其制备工艺
TW200410681A (en) Amino acid compound for improving central function
JP2004534073A5 (cg-RX-API-DMAC7.html)
Yagi et al. Inhibition of advanced glycation endproduct formation in amino acids
US20230083117A1 (en) Use of a combination of nitrogen and hydrogen based compounds with an amino acid and a stimulant
US20080089962A1 (en) Nutritional composition for facilitating muscle pumps